Decision of the EEA Joint Committee No 118/2024 of 12 June 2024 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/2472]
Date: 2024-06-12
Institutions: EEA Joint Committee
Subjects: European Economic Area, market approval, plant health control, plant health product, revision of an agreement, withdrawal from the market




L_202402472EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2024/2472


3.10.2024







            DECISION OF THE EEA JOINT COMMITTEE No 118/2024
of 12 June 2024
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/2472]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2023/2657 of 6 November 2023 concerning the non-renewal of the approval of the active substance benthiavalicarb, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2023/2455 of 7 November 2023 concerning the non-renewal of the approval of the active substance metiram, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2023/2592 of 21 November 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, 2-phenylphenol (incl. its salts such as sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fluazifop P, lenacil, napropamide, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, spiroxamine, sulphur, tetraconazole and tri-allate (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Regulation (EU) 2024/20 of 12 December 2023 concerning the non-renewal of the approval of the active substance S-metolachlor, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (4) is to be incorporated into the EEA Agreement.












(5)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:






1.


The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






‘—



32023 R 2657: Commission Implementing Regulation (EU) 2023/2657 of 6 November 2023 (OJ L, 2023/2657, 23.11.2023),










—



32023 R 2455: Commission Implementing Regulation (EU) 2023/2455 of 7 November 2023 (OJ L, 2023/2455, 8.11.2023),










—



32023 R 2592: Commission Implementing Regulation (EU) 2023/2592 of 21 November 2023 (OJ L, 2023/2592, 22.11.2023),










—



32024 R 0020: Commission Implementing Regulation (EU) 2024/20 of 12 December 2023 (OJ L, 2024/20, 3.1.2024).’














2.


The following points are inserted after point 13zzzzzzzzzzzzzz (Commission Implementing Regulation (EU) 2023/1756):






‘13zzzzzzzzzzzzzza.



32023 R 2657: Commission Implementing Regulation (EU) 2023/2657 of 6 November 2023 concerning the non-renewal of the approval of the active substance benthiavalicarb, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2023/2657, 23.11.2023).










13zzzzzzzzzzzzzzb.



32023 R 2455: Commission Implementing Regulation (EU) 2023/2455 of 7 November 2023 concerning the non-renewal of the approval of the active substance metiram, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2023/2455, 8.11.2023).










13zzzzzzzzzzzzzzc.



32024 R 0020: Commission Implementing Regulation (EU) 2024/20 of 12 December 2023 concerning the non-renewal of the approval of the active substance S-metolachlor, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2024/20, 3.1.2024).’










Article 2
The texts of Implementing Regulations (EU) 2023/2657, (EU) 2023/2455, (EU) 2023/2592 and (EU) 2024/20 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 13 June 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 12 June 2024.


For the EEA Joint Committee


The President

Nicolas VON LINGEN
            





(1)  
            OJ L, 2023/2657, 23.11.2023.

(2)  
            OJ L, 2023/2455, 8.11.2023.

(3)  
            OJ L, 2023/2592, 22.11.2023.

(4)  
            OJ L, 2024/20, 3.1.2024.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2024/2472/oj
ISSN 1977-0677 (electronic edition)